|
 |
 |
|
|
| |
|
|
| |
 |
The Centers for Medicare & Medicaid Services (CMS) announced they are
about to publish proposed Accountable Care Organization (ACO)
regulations under the Affordable Care Act's Shared Savings Program. The
regulations are expected to address a range of issues regarding various
aspects of ACO arrangements and operations under the program, which have
not been given significant detailed guidance to date.
Please join national experts from EpsteinBeckerGreen including Douglas
A. Hastings, David E. Matyas and Patricia M. Wagner in a thorough
examination and discussion of the new regulations, with a focus on
strategic implications for stakeholders from a legal and regulatory
perspective. |
| |
 |
Participants will be able to:
- Understand the scope and provisions of the new regulations
- Consider the short and long-term strategic implications for
stakeholders regarding these provisions
- Identify any significant ACO issues not adequately addressed by
the regulations
- Explore selected scenarios for stakeholders pursuing ACOs that
would be impacted by the regulations
- Engage in interactive learning through online question submission, attendee feedback and opportunity for
follow up questions, and networking with attendees, faculty and other
professionals through dedicated LinkedIn group
|
 |
Interested attendees would include:
- C-Suite Executives
- Strategy and Planning Executives and
Staff
- Legal, Regulatory and Policy
Executives and Staff
- Compliance Executives and Staff
- Medicare Operations Executives and Staff
- Managed Care and Revenue Cycle
Executives and Staff
- Business Development Executives
and Staff
- Provider Network
Executives and Staff
- Provider Contracting
Executives and Staff
- Medical Directors
Attendees would represent organizations
including:
- Hospitals
- Provider Networks
- Medical Groups
- Health Plans
- Business Process Organizations
- Solutions Providers
- Care Management Organizations
- Associations, Institutes and
Research Organizations
- Pharmaceutical Organizations
- Media
- Other Interested Parties
|
|
 |
Individual Registration Fee: $195. Audio Conference CD-ROM: $40
for attendees; $255 for non-attendees after the event.
Corporate Site licensing also available. Click
here to register or call 209.577.4888 We look forward to your
participation in this event!
|
| |
 |
| |
|
| |
|
Douglas A. Hastings
Chair of the Board of Directors,
EpsteinBeckerGreen
|
|
|
Douglas A. Hastings currently serves as
Chair of the Board of Directors of Epstein Becker & Green,
P.C. He is a Member of the Firm's Health Care and Life
Sciences Practice in the Washington, DC office. Mr. Hastings
provides a wide range of health care organizations with
strategic and transactional legal guidance in responding to
the legal challenges and opportunities of the rapidly
changing U.S. health care system.
Mr. Hastings serves on the Board on Health Care Services of
the Institute of Medicine and is a member of the Advisory
Board of the BNA's Health Law Reporter. He served on the
Board of Directors of the American Health Lawyers
Association from 1991 to 2003, and was President of that
organization for 2001-2002.
Mr. Hastings' clients include academic medical centers;
hospitals and health systems; faculty practices, medical
groups and other physician organizations; health plans and
other managed care organizations; long-term care facilities;
investment banks and venture funds; and other health
care-related entities. He focuses on representing these
organizations in mergers, acquisitions, joint ventures,
governance issues, complex contractual arrangements and
other affiliations and collaborative efforts. Mr. Hastings
and his colleagues also provide his clients with a full
range of legal advice and services, including: antitrust
law; Medicare reimbursement and other third party payment
issues; Stark, fraud and abuse, and other health care
compliance issues; tax and tax-exempt counseling; privacy
law; bankruptcy and restructuring; real estate and
construction law; labor and employment law; and liability
and litigation matters.
Mr. Hastings has been named by Best Lawyers as the
"Washington, DC Health Care Lawyer of the Year" for 2010. He
is listed in Chambers USA Leading Lawyers for Business, The
Best Lawyers in America, Washington DC Super Lawyers, and
Who's Who in American Law. In 2006, Mr. Hastings was named
one of the DC Area's Top Life Sciences Attorneys by the
Legal Times. In 2004, Nightingale's Healthcare News listed
him as one of the nation's leading healthcare transaction
lawyers. In 1997, the National Law Journal named him as one
of "40 Health Care Lawyers Who Have Made Their Mark." From
1991 through 1999, he served as Program Chair of the Managed
Care Law Institute of the American Health Lawyers
Association. He is a graduate of Duke University and the
University of Virginia Law School.
Mr. Hastings speaks and publishes regularly on topics
related to health care law, complex health care
transactions, corporate governance, collaborative health
care ventures, legal issues related to quality improvement
and the legal trends influencing the U.S. health care
system.
|
|
| |
|
David E. Matyas
Member of the Firm, EpsteinBeckerGreen
|
|
David E. Matyas is a Member of EpsteinBeckerGreen in the Health Care and
Life Sciences Practice in the firm's Washington, DC office. He practices
in the firm's Health Care Fraud Practice Group, which focuses on federal
and state fraud issues such as anti-kickback, self-referral, false
claims and regulatory compliance. Mr. Matyas also practices in the
firm's Third-Party Payment Practice Group, which concentrates on legal
and regulatory matters arising under Medicare, Medicaid, and other
third-party payment programs. Mr. Matyas represents an array of health
care providers including hospitals and health systems, pharmaceutical
and medical device manufacturers, academic medical centers, retail and
specialty pharmacies, ambulatory surgery centers, home health agencies,
and physician organizations. He also advises investors and other
financial institutions that invest in or support the health care
industry.
Mr. Matyas: Represents and defends health care entities in connection
with government audits and investigations; • Helps clients develop,
implement and evaluate health care corporate compliance programs;
•Counsels clients in planning and structuring transactions and business
arrangements to minimize fraud and abuse and understand reimbursement
implications in matters related to health care transactions; •Advises
clients on legal and regulatory matters in connection with investment
documents, offering memoranda, filings with the SEC and other
transactional documents; •Participates in administrative rulemaking
processes.
From 2005-2008, Mr. Matyas had been appointed by the Secretary of the
Department of Health & Human Services to the Advisory Committee on Blood
Safety & Availability, which provides advice on broad public health,
ethical and legal issues related to the nation's supply of blood and
blood products. From 2002-2008, Mr. Matyas served as a member of the
Board of Directors for the American Health Lawyers Association, and he
continues to chair the association's Fundamentals of Health Law Program.
In 2005 and in 2010, Mr. Matyas was selected by the editors of
Nightingale's Healthcare News as one of the "Outstanding Fraud &
Compliance Lawyers." Mr. Matyas is also listed in the District of
Columbia Healthcare category of Chambers USA and in Washington, D.C.
Super Lawyers magazine.
Mr. Matyas has served as an Adjunct Professor of Law at American
University's Washington School of Law. He is a frequent speaker and
author on the subjects of health care fraud, corporate compliance
programs, the Stark Law, mergers and acquisitions in the health care
industry, and other health-related topics. Mr. Matyas is the co-author
of the book entitled Legal Issues in Health Care Fraud and Abuse:
Navigating the Uncertainties, of which the 3rd edition was published in
2006.
|
|
| |
|
Patricia M. Wagner
Member of the Firm, EpsteinBeckerGreen
|
|
Patricia M. Wagner is a Member of EpsteinBeckerGreen in the Health Care
and Life Sciences Practice in the firm's Washington, DC office.
Ms. Wagner's experience includes the following: •Advising clients on a
variety of matters related to federal and state antitrust issues;
•Representing clients in antitrust matters in front of the Federal Trade
Commission and the United States Department of Justice; •Advising
clients on issues related HIPAA Privacy and HIPAA portability
provisions; •Advising clients on issues related to state licensure and
regulatory requirements; •Advising clients on various other federal
regulatory matters.
Her Presentations and Articles include: •Lecturer in DC Bar Introduction
to Health Law Series; Managed Care Contracting, 2005-2009; •Presentation
for Lorman Group, Privacy Compliance for Medical Records, (February
2008, November 2008, and December 2008); •Presenter in Webinar, HIPAA
and Wellness Programs, (March 2007); •William G. Kopit & Patricia M.
Wagner, 39 J. Health L., Dagher Redux: Searching for the Missing Pieces
(Summer 2006); •Presentation, Employer Handling Of Health Information:
What Employers Need To Know About Privacy and Security of Group Health
Plan Information, Epstein, Becker & Green, P.C. Client Briefing;
•Presentation for AAIHDS, Legal/Legislative Issues Affecting Managed
Care, (Nov. 2004); •Presentation for Lorman Group, Privacy Compliance
for Medical Records, (Oct. 2002);
Prior to practicing law, Ms. Wagner received her doctorate in
microbiology (1990) from the University of Kansas. With that degree, she
worked as a research microbiologist at a number of research institutions
around the country, including the Centers for Disease Control in
Atlanta, Georgia. |
|
| |
 |
|
-
1101 Standiford Ave. Suite C-3 Modesto, CA 95350
Phone 209.577.4888 |
e-Mail
infohws@healthwebsummit.com
| Fax
209.577.3557
- copyright
, MCOL All rights reserved. Terms
of Use apply to this site and participation in events.
|
|
New CMS ACO Shared Savings Program Regulations